Brendon O'Connell1, Nazar Hafiz2, Seth Crockett3. 1. Department of Medicine, University of North Carolina School of Medicine, CB 7080, Chapel Hill, NC, 27599, USA. 2. Department of Medicine, Louisiana State University Health Sciences Center, Shreveport, LA, USA. 3. Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, NC, USA. sethc@med.unc.edu.
Abstract
PURPOSE OF REVIEW: In this manuscript, we review current surveillance guidelines for serrated polyps (SPs) and discuss how recent studies inform the selection of appropriate surveillance intervals for patients with SPs. RECENT FINDINGS: Large and/or proximal SPs, particularly sessile serrated polyps (SSPs), are associated with increased risk of both synchronous and metachronous neoplasia, including advanced adenomas and colorectal cancer (CRC). Persons harboring multiple SSPs or dysplastic SSPs are at the highest risk. Moreover, a high percentage of large and/or proximal SPs are reclassified as SSPs when read by trained gastrointestinal pathologists, even if they were originally reported as hyperplastic polyps. These findings support the adoption of surveillance guidelines that prescribe closer surveillance of large and/or proximal SPs, regardless of subtype. SSPs remain a challenge to reliably identify, resect, and diagnose via histology. The increased risk of future neoplasia in patients with SSPs is likely driven by a combination of underdetection, inadequate removal, misclassification, and biology. Until further evidence emerges, we support guidelines that recommend close surveillance of patients with a history of large and/or proximal SPs and SSPs specifically in order to mitigate the threat of interval CRC.
PURPOSE OF REVIEW: In this manuscript, we review current surveillance guidelines for serrated polyps (SPs) and discuss how recent studies inform the selection of appropriate surveillance intervals for patients with SPs. RECENT FINDINGS: Large and/or proximal SPs, particularly sessile serrated polyps (SSPs), are associated with increased risk of both synchronous and metachronous neoplasia, including advanced adenomas and colorectal cancer (CRC). Persons harboring multiple SSPs or dysplastic SSPs are at the highest risk. Moreover, a high percentage of large and/or proximal SPs are reclassified as SSPs when read by trained gastrointestinal pathologists, even if they were originally reported as hyperplastic polyps. These findings support the adoption of surveillance guidelines that prescribe closer surveillance of large and/or proximal SPs, regardless of subtype. SSPs remain a challenge to reliably identify, resect, and diagnose via histology. The increased risk of future neoplasia in patients with SSPs is likely driven by a combination of underdetection, inadequate removal, misclassification, and biology. Until further evidence emerges, we support guidelines that recommend close surveillance of patients with a history of large and/or proximal SPs and SSPs specifically in order to mitigate the threat of interval CRC.
Authors: Baojin Fu; Shinichi Yachida; Richard Morgan; Yi Zhong; Elizabeth A Montgomery; Christine A Iacobuzio-Donahue Journal: Am J Clin Pathol Date: 2012-09 Impact factor: 2.493
Authors: Pelvender Gill; Lai Mun Wang; Adam Bailey; James E East; Simon Leedham; Runjan Chetty Journal: J Clin Pathol Date: 2013-04-10 Impact factor: 3.411
Authors: Douglas K Rex; Dennis J Ahnen; John A Baron; Kenneth P Batts; Carol A Burke; Randall W Burt; John R Goldblum; José G Guillem; Charles J Kahi; Matthew F Kalady; Michael J O'Brien; Robert D Odze; Shuji Ogino; Susan Parry; Dale C Snover; Emina Emilia Torlakovic; Paul E Wise; Joanne Young; James Church Journal: Am J Gastroenterol Date: 2012-06-19 Impact factor: 10.864
Authors: Rune Erichsen; John A Baron; Stephen J Hamilton-Dutoit; Dale C Snover; Emina Emilia Torlakovic; Lars Pedersen; Trine Frøslev; Mogens Vyberg; Stanley R Hamilton; Henrik Toft Sørensen Journal: Gastroenterology Date: 2015-12-08 Impact factor: 22.682
Authors: Bishnu P Joshi; Zhenzhen Dai; Zhenghong Gao; Jeong Hoon Lee; Navin Ghimire; Jing Chen; Anoop Prabhu; Erik J Wamsteker; Richard S Kwon; Grace H Elta; Elena M Stoffel; Asha Pant; Tonya Kaltenbach; Roy M Soetikno; Henry D Appelman; Rork Kuick; D Kim Turgeon; Thomas D Wang Journal: Gastroenterology Date: 2016-12-22 Impact factor: 22.682
Authors: Else-Mariëtte B van Heijningen; Iris Lansdorp-Vogelaar; Ewout W Steyerberg; S Lucas Goede; Evelien Dekker; Wilco Lesterhuis; Frank ter Borg; Juda Vecht; Pieter Spoelstra; Leopold Engels; Clemens J M Bolwerk; Robin Timmer; Jan H Kleibeuker; Jan J Koornstra; Harry J de Koning; Ernst J Kuipers; Marjolein van Ballegooijen Journal: Gut Date: 2015-01-13 Impact factor: 23.059
Authors: Jane C Figueiredo; Seth D Crockett; Dale C Snover; Carolyn B Morris; Gail McKeown-Eyssen; Robert S Sandler; Dennis J Ahnen; Douglas J Robertson; Carol A Burke; Robert S Bresalier; James M Church; Timothy R Church; John A Baron Journal: Cancer Causes Control Date: 2014-12-24 Impact factor: 2.506
Authors: Seth D Crockett; Rebecca A Gourevitch; Michele Morris; David S Carrell; Sherri Rose; Zhuo Shi; Julia B Greer; Robert E Schoen; Ateev Mehrotra Journal: Endoscopy Date: 2018-04-24 Impact factor: 10.093